Haemonetics (HAE) Tax Provisions (2009 - 2026)

Haemonetics has reported Tax Provisions for 18 years, with the latest figure at -$8.3 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions fell 164.89% year-over-year to -$8.3 million; the trailing twelve-month figure through Mar 2026 stood at $30.7 million (down 30.87% YoY), and the FY2026 full-year result was $30.7 million, down 30.79% from the prior year.
• Tax Provisions for Q1 2026 stood at -$8.3 million, down from $15.2 million in the prior quarter.
• The five-year high for Tax Provisions was $15.2 million in Q4 2025, with the low at -$8.3 million in Q1 2026.
• Average Tax Provisions over 5 years is $8.3 million, with a median of $8.8 million recorded in 2024.
• Year-over-year, Tax Provisions surged 324.21% in 2025 and slumped 164.89% in 2026.
• Tracing HAE's Tax Provisions over 5 years: stood at $9.3 million in 2022, then jumped by 37.8% to $12.8 million in 2023, then slipped by 2.85% to $12.4 million in 2024, then increased by 22.35% to $15.2 million in 2025, then plunged by 154.46% to -$8.3 million in 2026.
• The last three Tax Provisions figures came in at -$8.3 million (Q1 2026), $15.2 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.

Peer Comparison